c*****a
发帖数: 845 | 1 职位1）美国某CRO公司 在国内的子公司，工作地 上海
有机合成高级研究员，需要美国的化学专业的博士，0-4年博后或工作经验，有机方法
学或全合成方向
合成部助理主任或副主任，需要美国的化学专业的博士，4年以上工作经验，有一定的
团队管理经历
职位2）某国内医药研发龙头企业 ，工作地 上海
药物化学高级研究员或组长，助理主任 需要美国化学专业的博士，熟悉药物化学和
新药研发流程
职位3）global big pharma (江苏)API工艺研究员，需要博士，英语流利，有机方法学
或全合成方向，有企业工作经验优先
职位4）Head of BioPharma industry- 大分子生物制药副总经理（江苏）
要求：
1. 硕士或博士相关学历；
2. 具有10年以上国际制药公司生物药物生产管理经验，特别是具有抗体药物临床生
产经验；
3. 具有丰富的cGMP经验；
4. 具有3年以上团队管理经验；
5. 在大规模细胞培养，生产规模抗体纯化，超滤，制剂及灌装方面有较丰富经验；
6. 熟悉生物分析方法的建立开发及验证；
7. 熟悉生产计划及物流管理... 阅读全帖 |
|
C****3
发帖数: 162 | 2 Great leadership opportunity in a major Biopharma company in China. If
interested, please contact Maren Ma directly:
Mobile: +86 137 0193 2036
Tel: +86 21 6240 2111*1024
Fax: +86 21 6240 8433
Email: [email protected]
/* */
Web: www.fortune-career.com
-------------------------------------------------------------------
My client is seeking a Biological Process Lead (AD Level), if your friends
interested in this position, welcome to contact me.
Biological Process Lead
Reports to R&D Director
... 阅读全帖 |
|
t**n
发帖数: 4365 | 3 大的制药公司，除了biotech出身的，还是不会叫自己biotech的，一般叫biopharma |
|
t**n
发帖数: 4365 | 4 大的制药公司，除了biotech出身的，还是不会叫自己biotech的，一般叫biopharma |
|
发帖数: 1 | 5 各位前辈大侠
求推荐一个在NJ的药厂的工作，不想在和男票异地了。目前在biopharma做contractor
，有过9个月的经验， 主要做一些antibody的characterization，做peptide mapping
和intact mass，现在可以用OPT工作，是analytical chemistry的PhD，谢谢了。有消
息的能短我么？我可以email我的简历 |
|
x****o
发帖数: 60 | 6 【 以下文字转载自 JobHunting 讨论区 】
发信人: xiaoao (吃了睡,睡了再吃), 信区: JobHunting
标 题: analytical scientist opportunity (Boston area)
关键字: analytical job,Boston area,biopharma
发信站: BBS 未名空间站 (Sun May 15 14:01:14 2016, 美东)
A long-term contract job opportunity is available in the Boston area. The
person will work for a big biopharmaceutical company through a third party.
The Contract Personnel will have the following minimum requirements:
• BA or BS in Chemistry, Biochemistry, Biology, Microbiology or
e... 阅读全帖 |
|
C****3
发帖数: 162 | 7 Carol Huang Principal Consultant BioPharma R&D Recruitment EastWest
Recruiting LLC Tel: +1 (781) 561-7555 Cell: +1 (818) 653-1709 carol@
eastwestrecruiting.com
Principal Scientist/Associate Director/Director Biologics Formulation
ChemPartner Co., Ltd
1. Have a sound knowledge of the requirements of product development through
the development lifecycle, have contributed to PPD reviews and will have
contributed to the preparation of regulatory documents.
2. Have demonstrated ability in leading for... 阅读全帖 |
|
发帖数: 1 | 8 bioinformatics PhD＋Statistics MS＋Postdoc做cancer genomics／NGS data＋3篇一
作(IF15~30不等）。
借宝地求个biopharma or biotech 内推，谢谢！另外本人正处于职业发展迷茫期， 求
各位大侠指点，谢谢。。。
补充下：
主要困惑是，将来朝着哪个方向发展。 1）做bioinformatics，短期内似乎比较容易找
工，但是有远虑，担心长远发展不好 2）是不是应该向data scientist 发展，
machine learning我还可以，但是computer方面还需补一补，应该考虑吗？ 3）做常规
analyst，比如risk analyst，predictive modeling？然后慢慢向business 靠近？
实在是周围没有多少人可以参考，请高人赐教，不甚感激。 。。。 |
|
发帖数: 1 | 9 Welcome To Attend The 2nd Annual Conference of Chinese Antibody Society
The Chinese Antibody Society is going to host the Second Annual Conference
with a theme of “Therapeutic Antibodies: Frontiers and Opportunities” on
April 29th, 2018 in Cambridge, MA. The conference will discuss the antibody-
related technological advances, challenges and opportunities in discovery,
development, clinical trials, patent and biosimilar of therapeutic
antibodies as well as the progress of immuno-oncology.
Chines... 阅读全帖 |
|
发帖数: 1 | 10 Welcome To Attend The 2nd Annual Conference of Chinese Antibody Society
The Chinese Antibody Society is going to host the Second Annual Conference
with a theme of “Therapeutic Antibodies: Frontiers and Opportunities” on
April 29th, 2018 in Cambridge, MA. The conference will discuss the antibody-
related technological advances, challenges and opportunities in discovery,
development, clinical trials, patent and biosimilar of therapeutic
antibodies as well as the progress of immuno-oncology.
Chines... 阅读全帖 |
|
s********d
发帖数: 103 | 11 Alnylam and Ascletis collaborate to develop ALN-VSP for liver cancers in
China
US RNAi therapeutics specialties Alnylam Pharmaceuticals (Nasdaq: ALNY) and
Ascletis Pharmaceuticals, a privately held US-China joint venture
pharmaceutical company, have formed a strategic collaboration for the
development of ALN-VSP, a first-in-class, systemically delivered RNAi
therapeutic for the treatment of liver cancers including hepatocellular
carcinoma (HCC), a significant area of unmet need in China.
This co... 阅读全帖 |
|
h*******n
发帖数: 95 | 12 【 以下文字转载自 WashingtonDC 讨论区 】
发信人: hydration (hydration), 信区: WashingtonDC
标 题: 招聘 administrative Assistant 秘书兼出纳员一名
发信站: BBS 未名空间站 (Thu Jun 23 21:19:27 2011, 美东)
YiSheng US BioPharma, Inc., located in Gaithersburg, is looking for a full-
time secretary with experience in handling administrative functions
including bookkeeping, purchasing and travel arrangements. Candidate must
possess skills in multi-tasking, computer skills, and strong written and
oral communication for both English and Chines... 阅读全帖 |
|
y******1
发帖数: 730 | 13 【 以下文字转载自 Stock 讨论区 】
发信人: yoren001 (Ajie), 信区: Stock
标 题: HEB news-New Infectious Retrovirus Detected in Chronic Fatigue Syndrome
发信站: BBS 未名空间站 (Tue Oct 13 11:10:13 2009, 美东)
http://www.reuters.com/article/pressRelease/idUS102982+13-Oct-2009+GNW20091013
PHILADELPHIA, Oct. 13, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (
NYSE
Amex:HEB) (the "Company") announced today that the discovery of a novel
retrovirus in CFS may now shed new light on the potential mechanism of
action of
Ampligen |
|
|
n*******r
发帖数: 425 | 15 Mon:
Earnings: Legend International Holdings (LGDI), Span-America Medical Systems
(SPAN), Dixie (DXYN), Waterstone Financial (WSBF), ZBB Energy (ZBB), Opexa
Therapeutics (OPXA), Industrial Services of America (IDSA), Marina Biotech (
MRNA), Hemispherx Biopharma (HEB), Ascent Solar Technologies (ASTI),
BancTrust Financial (BTFG), Uranium One (SXRZF), Roma Financial (ROMA),
Constellation Energy Partners (CEP), Reading International (RDI), ID Systems
(IDSY), Princeton National Bancorp (PNBC), China... 阅读全帖 |
|
|
m*z
发帖数: 2356 | 17 Cytec Industries Inc. (NYSE:CYT) shares jumped 12.18% in after hours trading
on volume of 34,640 shares traded.
Mindray Medical International Limited (NYSE:MR) shares jumped 9.90% in after
hours trading on volume of 27,545 shares traded.
United Rentals, Inc. (NYSE:URI) shares jumped 7.28% in after hours trading
today on volume of 12,204 shares traded.
SLM Corporation (NYSE:SLM) shares jumped 5.92% in after hours trading today
on volume of 67,357 shares traded.
Lincare Holdings Inc. (NASDAQ:LNCR)... 阅读全帖 |
|
f**********g
发帖数: 2252 | 18 盘中动态 -- 美股走跌，科技股领跌
美股周三盘中下跌，科技股领跌。投资人忧心联准会可能采取的措施，引发大盘走跌。
另一方面，原油库存意外下滑，带动能源类股上扬。
道琼工业指数盘中下跌0.23点，来到10857.91点，跌幅0.002%。那斯达克指数下跌0.38
点，来到2379.21点，跌幅0.016%。S&P 500上涨0.52点，来到1148.22点，跌幅0.045%
。
Jack in the Box (JACK: 报价, 研究资料) 周三表示，将在10月3日的会计年度结束前
关闭40家直营餐厅。主要是集中在美国东南部和德州的餐厅。公司并表示，亏损费用约
在850~950万美元，以及2100~2500万美元的租赁相关成本。
Family Dollar (FDO: 报价, 研究资料) 周三表示，本会计年度第四季获利成长23%，
至7400万美元，即每股56美分，优於去年同期的6010万美元，即每股43美分。分析师原
先预估EPS为51美分。营收成长8%至19.6亿美元。公司表示，库存萎缩的情形减少，加
上购买量上升，弥补升高的货运支出和低利润商品销售增加的部分。公司预估20... 阅读全帖 |
|
f**********g
发帖数: 2252 | 19 All old friends in the club, include sppi.
Array Biopharma (ARRY: 报价, 研究资料) 发表Arry-520第一阶段临床实验数据为正
面，数据显示ARRY-520耐受度佳，治疗多发性骨髓瘤，ARRY-520目前进行1b阶段的混和
药剂实验。30位具有参考价值的病人当中，两人产生局部反应。
Cyclacel Pharma (CYCC: 报价, 研究资料) 发表第二阶段临床实验数据为正面，以口
服胶囊sapacitabine治疗骨髓化生不良症候群的老年病患，这些病人先前对
azacitidine与decitabine之类药物产生抗药性。29%的A组病人达到存活1年的主要实验
目标，B组为30%，C组为35%。 |
|
f**********g
发帖数: 2252 | 20 CEO has 526,000 shares!
7.Vical Inc. (VICL): Vical is a $142 million biopharma engaged in the
development of treatments using its DNA delivery technology. They have a
number of drugs at different stages of development and testing. The stock
traded near $4 in September, but poor results from a clinical trial and a
secondary offering priced at $2.25 cut the legs out of the share price. CEO
Vijay Samant picked up 500 shares on February 4 for $1,000. You have to
wonder why it was even worth the trou... 阅读全帖 |
|
f**********g
发帖数: 2252 | 21 CEO has 526,000 shares!
7.Vical Inc. (VICL): Vical is a $142 million biopharma engaged in the
development of treatments using its DNA delivery technology. They have a
number of drugs at different stages of development and testing. The stock
traded near $4 in September, but poor results from a clinical trial and a
secondary offering priced at $2.25 cut the legs out of the share price. CEO
Vijay Samant picked up 500 shares on February 4 for $1,000. You have to
wonder why it was even worth the trou... 阅读全帖 |
|
f**********g
发帖数: 2252 | 22 Seven Stocks With CEO Buying in the Past Week
by: Steven Kiel February 08, 2011 |
about: ACLS / BKMU / MOFG / NL / NPTN / ORI / VICL
http://seekingalpha.com/article/251438-seven-stocks-with-ceo-bu
When looking at insider purchases, CEO and CFO buying is a better indicator
than board purchases. Since management is dealing with day to day matters,
they have a better idea of what may be a positive catalyst for the stock.
These are great indicators because insiders only make purchases on the open... 阅读全帖 |
|
f**********g
发帖数: 2252 | 23 Seven Stocks With CEO Buying in the Past Week
by: Steven Kiel February 08, 2011 |
about: ACLS / BKMU / MOFG / NL / NPTN / ORI / VICL
http://seekingalpha.com/article/251438-seven-stocks-with-ceo-bu
When looking at insider purchases, CEO and CFO buying is a better indicator
than board purchases. Since management is dealing with day to day matters,
they have a better idea of what may be a positive catalyst for the stock.
These are great indicators because insiders only make purchases on the open... 阅读全帖 |
|
f**********g
发帖数: 2252 | 24 BIO CEO Conference Live Blog: Day 2
By Adam Feuerstein 02/15/11 - 07:00 AM EST
Stock quotes in this article:CLDA, AVII, NEOP, YMI, ZIOP, CTIC, ASTM
http://www.thestreet.com/_yahoo/story/11008155/1/bio-ceo-confer
NEW YORK (TheStreet) -- Small- and midsized biotech companies get a second day in the investor spotlight this week at the 13th annual BIO CEO & Investor Conference.
I'll be continuing my live-blogging from the BIO CEO conference today, presenting news updates and analysis live from th... 阅读全帖 |
|
f**********g
发帖数: 2252 | 25 BIO CEO Conference Live Blog: Day 2
By Adam Feuerstein 02/15/11 - 07:00 AM EST
Stock quotes in this article:CLDA, AVII, NEOP, YMI, ZIOP, CTIC, ASTM
http://www.thestreet.com/_yahoo/story/11008155/1/bio-ceo-confer
NEW YORK (TheStreet) -- Small- and midsized biotech companies get a second day in the investor spotlight this week at the 13th annual BIO CEO & Investor Conference.
I'll be continuing my live-blogging from the BIO CEO conference today, presenting news updates and analysis live from th... 阅读全帖 |
|
|
|
|
|
y***q
发帖数: 4147 | 30 Do you think these stocks should be trading higher? Use this list as a
starting point for your own analysis.
List sorted by potential upside implied by target price.
1. Warren Resources Inc. (WRES): Engages in the exploration, development,
and production of onshore crude oil and gas reserves in the United States.
Market cap of $213.84M. Price (as of market close on 12/19) at $2.99. Of the
5 analysts that have set a target price on the stock, the lowest price
target stands at $4.00. This implies ... 阅读全帖 |
|
|
q********g
发帖数: 10694 | 32 观点很象这里Jenny12以前说的。从中也学习到一些分析医药股的方法。例文欣赏。
http://seekingalpha.com/article/895051-sarepta-therapeutics-loo
Sarepta Therapeutics Looks Highly Undervalued
September 28, 2012 | 37 commentsby: Sean Anderson | about: SRPT
R.S. Analytics wrote up the long case for Sarepta Therapeutics (SRPT)
earlier this month here. I agree with that thesis, and won't bore everyone
by repeating it here since R.S. did such a great job telling it already.
There are, however, a few points that I'd like to expand on.
In ... 阅读全帖 |
|
